Please login to the form below
liability
This page shows the latest liability news and features for those working in and with pharma, biotech and healthcare.
Generative AI is coming for healthcare
Who owns the liability for those decisions? For those of you who may instantly be thinking that we already use machines like X-rays, MRIs and PET scans to help us
Latest news
-
Johnson & Johnson’s strategy to resolve talcum powder lawsuits blocked by US appeals court
efficiently.'". “We do not duck an apparent irony: that J&J’s triple A-rated payment obligation for LTL’s liabilities, which it views as a generous protection it was never
-
Teva and Allergan finalise terms of US opioid settlements worth $6.6bn combined
As part of the settlements, the two companies said they have resolved their ongoing dispute over opioid liability, originating from Teva having acquired Allergan's generic drugs portfolio in 2016, including
-
AbbVie’s Allergan reaches proposed $2.37bn agreement to settle US opioid lawsuits
In a statement, Teva said the agreement was contingent upon settling an ongoing dispute with Allergan over opioid liability, having acquired the company’s generic drugs portfolio in 2016, including its
-
Teva reaches proposed $4.25bn agreement to settle US opioid lawsuits
Teva will also need to settle an ongoing dispute with Allergan over opioid liability, having acquired Allergan’s generic drugs business in 2016.
-
US bankruptcy judge approves Purdue Pharma’s $6bn opioid settlement plan
Although the settlement will end any civil claims made against the Sacklers over Purdue’s involvement in the opioid crisis, it does not make them exempt from future criminal liability.
More from news
Approximately 0 fully matching, plus 123 partially matching documents found.
Latest Intelligence
-
Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world
Emerging biopharma comes of age: advantages, but also liabilities. According to an IQVIA Clinical Development Trends Impact Assessment, EBCs account for 72% of late-stage pipeline activity, up from 61% ten
-
Changes to look out for in Medical Devices Regulations
For the first time, all actors in the supply chain have potential responsibility for any defect in devices, compared to the old Regulations which focused on the liability of manufacturers. ... chain leading to parties renegotiating contracts, assessing
-
Creating a successful global compliance programme
Additionally, Brazil’s Clean Companies Act applies strict liability regarding interactions with public officials, and South Korea’s Kim Young-ran Act has adopted a broader definition of public officials that
-
A catalyst for change
In addition, liabilities for non-compliance under the Policy are much stricter than before. ... independently. Stricter liabilities for non-compliance. The Policy, Law and Measures clarified the liabilities for non-compliance during the drug approval
-
Tightening medical device safety
Additionally, all relevant stakeholders are required to report all alleged infringements of their obligations to their national competent authorities, with liability shared by all the economic operators involved in the manufacturing, ... The regulations
More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.
Latest appointments
-
New Merck Foundation appoints Rasha Kelej
Rasha Kelej has been appointed chief executive officer for Merck KGaA’s non-profit limited liability company, The Merck Foundation.
-
INC Research hires former Pfizer senior director
In her new role at the contract research organisation (CRO) INC Research she will support the company's early phase business unit, providing scientific direction on matters related to abuse liability ... Dr Setnik's extensive knowledge and experience in
-
Covington boosts European life sciences group
Koyuncu has also worked in compliance, privacy and product liability matters, along with assisting life sciences clients with corporate transactions.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Getting personal with wearable tech
But less than half of participants felt that biometric data from wearables could provide a trigger for intervention – and indeed raises the legal issue of liability should anything go unnoticed.
-
Not all data is created equal
ideologies. The US focuses on limiting the liability of companies using data, through a variety of sector based Privacy legislation of which HIPAA – The federal Health Insurance Portability and Accountability Act ... liability for the data that is
-
Do you speak Human?
The financial and brand damage that ensues from mistranslation is already a significant liability, even with fully vetted human translation.”.
-
Indigenus Announces New Global Partnership with Insight
Indigenus was formed in 2004, and became an agency-owned Limited Liability Company in 2011.
-
Indigenus Announces New Global Partnership With CPC Healthcare
Indigenus was formed in 2004, and became an agency-owned limited liability company (LLC) in 2010.
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Springer Nature
Did you know that we publish over 3,000 journals, and that over 1,000 of those are clinical science journals? Promote...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
